Diabetes drug Ozempic® and similar medicines are growing in popularity with people 搜索ing for an effective appetite suppressant. While Ozempic is often praised for its off-label use as a weight loss aid, people who use it for long periods may risk health problems, including intestinal blockages and stomach paralysis. Wegovy®, 一种高剂量的奥兹匹克 that is FDA-approved to treat obesity, 也可能导致改变生活的影响.
Manufacturer Novo Nordisk does not list stomach paralysis (gastroparesis) intestinal blockages or pancreatic cancer, both potential and deadly gastric side effects of Ozempic and Wegovy, 作为他们警告的一部分. 结果是, patients may not know they are at risk for developing one of these serious conditions, both which can require hospitalizations and surgery to treat.
Our medical drug attorneys are investigating claims. If you took one of these drugs and suffered health problems, we want to talk with you about your legal options.
If you or a loved one suffered pancreatic cancer, intestinal blockage or stomach paralysis/gastroparesis after taking Ozempic, Wegovy or another GLP-1 Receptor drug for diabetes or weight loss, 你可以提出要求. 填写此网页表格 或者拨打1.800.768.4026联系律师 Sara坐在沙发上 for more information or to discuss a potential claim.
Ozempic was created and approved in 2017 to treat Type 2 diabetes. Ozempic上市后不久, 然而, clinicians observed that appetite suppression was a side effect and weight loss often occurred. 诺和诺德随后开发了Wegovy, 一种高剂量的奥兹匹克, which was approved by the FDA in June 2021 to treat certain patients suffering with weight gain and obesity. Since then, both drugs have surged in popularity, resulting in national shortages. 在一起, sales of these drugs reached nearly $10 billion in 2022, 处方继续飙升.
Wegovy和Ozempic的活性成分, semaglutide, 是GLP-1吗, 或者胰高血糖素样肽-1, which mimics the GLP-1 satiety hormone in our bodies. This allows the drug to target areas of the brain that regulate appetite and food intake. 根据FDA, the medication dose must be gradually increased weekly to reduce gastrointestinal side effects. 病人应该服用? stay on Wegovy long term – potentially for life – as studies show that stopping the drug results in rapid weight gain. 的 need to continuously take the drug long term also increases the risk of side effects.
的 食品及药物管理局宣布 in 2023 that complaints made through the FDA Adverse Event Reporting System (FAERS) indicate potential safety concerns for these drugs. This includes the risk of intestinal blockage, which can be serious and life-threatening.
已发表的研究 show patients taking semaglutide drugs such as Wegovy and Ozempic have an increased risk of intestinal obstructions. 的 risks of intestinal obstruction – a potentially fatal condition that often requires surgery – have been shown to increase by 3.5 to 4.服用GLP-1受体的患者为5倍. 的 FDA is now evaluating whether additional warnings are needed because of the intestinal obstruction reports. Intestinal blockage signs and symptoms may include:
- Trouble having a bowel movement or passing gas
Doctors have also recently reported patients with stomach paralysis, also called gastroparesis. Stomach paralysis prevents the stomach’s nerves and muscles from working properly and results in food sitting too long in the stomach. 胃轻瘫的常见症状包括:
五颜六色的大米 medical drug litigation experience
Our medical attorneys have represented thousands of patients seriously hurt by dangerous prescription and over-the-counter drugs. We understand that as a patient or family member, your knowledge of your or a loved one’s medications may be limited. If you believe a medicine made you sick or hurt you, our attorneys have the resources needed to thoroughly investigate and:
- Review the medicine manufacturer’s compliance with FDA regulations
- Confirm if the manufacture adequately warned you about potential side effects
- Identify anything the manufacturer did wrong or illegal concerning your medicine
- Recognize other issues that could affect your potential claim
Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor's advice can result in injury or death.